ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$3.49
+2.35% today
Updated 2026-04-30
Market cap
$3.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.56
Dividend yield
—
52W range
$3 – $86
Volume
4.2M
Artelo Biosciences Inc (ARTL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-125.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+89.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.2%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-24 | $-0.12 | +97.5% | $1.24 | $1.21 | -2.4% |
| 2025-11-12 | $-3.97 | -2814.8% | $1.96 | $1.80 | -8.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-4.71 | $-0.12 | +97.5% | — | — |
| 2025-09-30 | $-0.14 | $-3.97 | -2814.8% | — | — |
| 2025-06-30 | $-0.13 | $-5.61 | -4215.4% | — | — |
| 2025-03-31 | $-0.13 | $-0.72 | -453.8% | — | — |
| 2024-12-31 | $-0.38 | $-1.17 | -207.9% | — | — |
| 2024-09-30 | $-0.46 | $-0.34 | +25.9% | — | — |
| 2024-06-30 | $-0.85 | $-0.75 | +11.8% | — | — |
| 2024-03-31 | $-1.05 | $-0.78 | +25.7% | — | — |
| 2023-12-31 | $-0.56 | $-1.04 | -85.7% | — | — |
| 2023-09-30 | $-0.65 | $-0.83 | -27.7% | — | — |
| 2023-06-30 | $-0.81 | $-0.56 | +30.9% | — | — |
| 2023-03-31 | $-0.93 | $-0.76 | +18.3% | — | — |
Frequently asked questions
Has Artelo Biosciences Inc beaten earnings estimates?
Artelo Biosciences Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -125.6% over the last 4 quarters.
How does ARTL stock react to earnings?
ARTL stock has moved an average of -5.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.